Nevirapine (NVP) Use to Prevent Mother-to-Child Transmission of HIV
Status:
Completed
Trial end date:
2007-04-01
Target enrollment:
Participant gender:
Summary
HIV can be transmitted from an HIV infected mother to her infant through her breast milk. The
purpose of this study is to determine whether giving infants of HIV infected mothers the
anti-HIV drug nevirapine (NVP) for six weeks will reduce the risk of HIV transmission.
Study hypothesis: Six weeks of nevirapine prophylaxis provided to the infant will decrease
HIV transmission through breastfeeding.
Phase:
Phase 3
Details
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)